enow.com Web Search

  1. Ads

    related to: revlimid approved indications for diabetes management medication
    • Dosing Data

      Dosing Considerations And Data For

      US Healthcare Professionals.

    • Clinical Data

      Clinical Trial Data Presented For

      US Healthcare Professionals.

Search results

  1. Results from the WOW.Com Content Network
  2. Lenalidomide - Wikipedia

    en.wikipedia.org/wiki/Lenalidomide

    Lenalidomide, sold under the brand name Revlimid among others, is a medication used to treat multiple myeloma, smoldering myeloma, and myelodysplastic syndromes (MDS). [8] For multiple myeloma, it is a first line treatment, and is given with dexamethasone . [ 8 ]

  3. Revlimid Gains, Celgene Loses - AOL

    www.aol.com/news/2013-06-05-celgene-gains-new...

    Good newsThe U.S. Food and Drug Administration approved Revlimid as. Skip to main content. Sign in. Mail. 24/7 Help. For premium support please call: 800-290-4726 more ...

  4. Diabetes medication - Wikipedia

    en.wikipedia.org/wiki/Diabetes_medication

    Drugs used in diabetes treat types of diabetes mellitus by decreasing glucose levels in the blood. With the exception of insulin , most GLP-1 receptor agonists ( liraglutide , exenatide , and others), and pramlintide , all diabetes medications are administered orally and are thus called oral hypoglycemic agents or oral antihyperglycemic agents.

  5. Tafasitamab - Wikipedia

    en.wikipedia.org/wiki/Tafasitamab

    Tafasitamab, sold under the brand name Monjuvi, is a medication used in combination with lenalidomide for the treatment of adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL). [5] Tafasitamab may cause serious side effects including infusion related reactions, bone marrow suppression, infections, and harm to an unborn baby. [7]

  6. These 2 Stocks Just Declared Dividend Raises That Kick In ...

    www.aol.com/finance/2-stocks-just-declared...

    A pair of blockbuster cancer drugs, Revlimid and Abraxane, began falling off the patent cliff in 2022, and not coincidentally, the company's annual sales dipped in both that year and in 2023 ...

  7. Ozempic ‘microdosing’ is the new weight-loss trend: Should ...

    www.aol.com/news/ozempic-microdosing-weight-loss...

    A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic. With approximately 70% of American adults meeting the criteria for being obese or ...

  1. Ads

    related to: revlimid approved indications for diabetes management medication